Labcorp (LH) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$14.3B

Revenue (quarter)

$3.7B

Revenue growth (year over year)

+5.78%

Gross profit (trailing twelve months)

$4.1B

Gross margin

28.88%

Net income (trailing twelve months)

$1.0B

Net income (quarter)

$299.1M

Net income growth (year over year)

+25.51%

Net margin

6.99%

Return on equity

11.73%

EPS (trailing twelve months)

$12.17

Book value per share

$106.59

P/E (trailing twelve months)

25.50

Price to book

2.96

Debt to assets

53.47%

Payout ratio

27.39%

Dividend yield

0.93%

Company profile

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

• Is Labcorp (LH) profitable?

  Yes. Labcorp earned $1.0B in net income over the trailing twelve months, a net margin of 6.99%.

• How much revenue does Labcorp (LH) make?

  Labcorp generated $14.3B in revenue over the trailing twelve months, up 5.78% year over year.

• What is LH's P/E ratio?

  Labcorp trades at 25.5 times trailing twelve-month earnings, on an EPS of $12.17.

• How do I buy stock in Labcorp (LH)?

  LH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.